1.
Sadoul K, Khochbin S. The growing landscape of tubulin acetylation: lysine 40 and many more . Biochem J. 2016; ; 473 : :1859.–1868.
2.
Gadadhar S, Bodakuntla S, Natarajan K, Janke C. The tubulin code at a glance . J Cell Sci. 2017; ; 130 : :1347.–1353.
3.
L‘Hernault SW, Rosenbaum JL. Chlamydomonas alpha-tubulin is posttranslationally modified by acetylation on the epsilon-amino group of a lysine . Biochemistry. 1985;; 24 : :473.–8.
4.
Akella JS, Wloga D, Kim J, et al. MEC-17 is an alpha-tubulin acetyltransferase . Nature. 2010; ; 467 : :218.–222.
5.
Nogales E, Whittaker M, Milligan RA, Downing KH. High-resolution model of the microtubule . Cell. 1999; ; 96 : :79.–88.
6.
Szyk A, Deaconescu AM, Spector J, et al. Molecular basis for age-dependent microtubule acetylation by tubulin acetyltransferase . Cell. 2014; ; 157 : :1405.–1415.
7.
Coombes C, Yamamoto A, McClellan M, et al. Mechanism of microtubule lumen entry for the alpha-tubulin acetyltransferase enzyme alphaTAT1 . Proc Natl Acad Sci U S A. 2016; ; 113 : :E7176.–E7E84.
8.
Montagnac G, Chavrier P. Quand les microtubules rencontrent les puits recouverts de clathrine et permettent aux cellules de tenir le cap . Med Sci (Paris). 2014; ; 30 : :130.–133.
9.
Hubbert C, Guardiola A, Shao R, et al. HDAC6 is a microtubule-associated deacetylase . Nature. 2002; ; 417 : :455.–458.
10.
North BJ, Marshall BL, Borra MT, et al. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase . Mol Cell. 2003; ; 11 : :437.–444.
11.
Skultetyova L, Ustinova K, Kutil Z, et al. Human histone deacetylase 6 shows strong preference for tubulin dimers over assembled microtubules . Sci Rep. 2017; ; 7 : :11547..
12.
Skoge RH, Ziegler M. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6 . J Cell Sci. 2016; ; 129 : :2972.–2982.
13.
Park IY, Powell RT, Tripathi DN, et al. Dual Chromatin and Cytoskeletal Remodeling by SETD2 . Cell. 2016; ; 166 : :950.–962.
14.
Alonso VL, Ritagliati C, Cribb P, et al. Overexpression of bromodomain factor 3 in Trypanosoma cruzi (TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors . FEBS J. 2016; ; 283 : :2051.–2066.
15.
Portran D, Schaedel L, Xu Z, et al. Tubulin acetylation protects long-lived microtubules against mechanical ageing . Nat Cell Biol. 2017; ; 19 : :391.–398.
16.
Howes SC, Alushin GM, Shida T, et al. Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure . Mol Biol Cell. 2014; ; 25 : :257.–266.
17.
Barra HS, Unates LE, Sayavedra MS, Caputto R. Capacities for binding amino acids by tRNAs from rat brain and their changes during development . J Neurochem. 1972; ; 19 : :2289.–2297.
18.
Aillaud C, Bosc C, Saoudi Y, et al. Evidence for new C-terminally truncated variants of alpha- and beta-tubulins . Mol Biol Cell. 2016; ; 27 : :640.–653.
19.
Paturle-Lafanechere L, Manier M, Trigault N, et al. Accumulation of delta 2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies . J Cell Sci. 1994; ; 107 : :1529.–1543.
20.
Paturle-Lafanechere L, Edde B, Denoulet P, et al. Characterization of a major brain tubulin variant which cannot be tyrosinated . Biochemistry. 1991; ; 30 : :10523.–10528.
21.
Lafanechere L, Job D. The third tubulin pool . Neurochem Res. 2000; ; 25 : :11.–18.
22.
Erck C, Peris L, Andrieux A, et al. A vital role of tubulin-tyrosine-ligase for neuronal organization . Proc Natl Acad Sci U S A. 2005; ; 102 : :7853.–7858.
23.
Prota AE, Magiera MM, Kuijpers M, et al. Structural basis of tubulin tyrosination by tubulin tyrosine ligase . J Cell Biol. 2013; ; 200 : :259.–270.
24.
Wehland J, Weber K. Tubulin-tyrosine ligase has a binding site on beta-tubulin: a two-domain structure of the enzyme . J Cell Biol. 1987; ; 104 : :1059.–1067.
25.
Dal Piaz F, Vassallo A, Lepore L, et al. Sesterterpenes as tubulin tyrosine ligase inhibitors. First insight of structure-activity relationships and discovery of new lead . J Med Chem. 2009;; 52 : :3814.–28.
26.
Aillaud C, Bosc C, Peris L, et al. Vasohibins/SVBP are tubulin carboxypeptidases (TCPs) that regulate neuron differentiation . Science. 2017; ; 358 : :1448.–1453.
27.
Nieuwenhuis J, Adamopoulos A, Bleijerveld OB, et al. Vasohibins encode tubulin detyrosinating activity . Science. 2017; ; 358 : :1453.–1456.
28.
Fonrose X, Ausseil F, Soleilhac E, et al. Parthenolide inhibits tubulin carboxypeptidase activity . Cancer Res. 2007; ; 67 : :3371.–3378.
29.
Barisic M Silva e Sousa R, Tripathy SK, et al. Mitosis. Microtubule detyrosination guides chromosomes during mitosis . Science. 2015; ; 348 : :799.–803.
30.
Peris L, Thery M, Faure J, et al. Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends . J Cell Biol. 2006; ; 174 : :839.–849.
31.
Peris L, Wagenbach M, Lafanechere L, et al. Motor-dependent microtubule disassembly driven by tubulin tyrosination . J Cell Biol. 2009; ; 185 : :1159.–1166.
32.
Dunn S, Morrison EE, Liverpool TB, et al. Differential trafficking of Kif5c on tyrosinated and detyrosinated microtubules in live cells . J Cell Sci. 2008; ; 121 : :1085.–1095.
33.
d‘Ydewalle C, Krishnan J, Chiheb DM, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease . Nat Med. 2011;; 17 : :968.–74.
34.
Butler D, Bendiske J, Michaelis ML, et al. Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers . Eur J Pharmacol. 2007; ; 562 : :20.–27.
35.
Dompierre JP, Godin JD, Charrin BC, et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington‘s disease by increasing tubulin acetylation . J Neurosci. 2007; ; 27 : :3571.–3583.
36.
Godena VK, Brookes-Hocking N, Moller A, et al. Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations . Nat Commun. 2014; ; 5 : :5245..
37.
Patel VP, Chu CT. Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson‘s disease . Exp Neurol. 2014; ; 257 : :170.–181.
38.
Marcos S, Moreau J, Backer S, et al. Tubulin tyrosination is required for the proper organization and pathfinding of the growth cone . PLoS One. 2009; ; 4 : :e5405..
39.
Konishi Y, Setou M. Tubulin tyrosination navigates the kinesin-1 motor domain to axons . Nat Neurosci. 2009; ; 12 : :559.–567.
40.
Gobrecht P, Andreadaki A, Diekmann H, et al. Promotion of functional nerve regeneration by inhibition of microtubule detyrosination . J Neurosci. 2016; ; 36 : :3890.–3902.
41.
Gu S, Liu Y, Zhu B, et al. Loss of alpha-tubulin acetylation is associated with TGF-beta-induced epithelial-mesenchymal transition . J Biol Chem. 2016; ; 291 : :5396.–5405.
42.
Boggs AE, Vitolo MI, Whipple RA, et al. Alpha-tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration . Cancer Res. 2015; ; 75 : :203.–215.
43.
Oh S, You E, Ko P, et al. Genetic disruption of tubulin acetyltransferase, alphaTAT1, inhibits proliferation and invasion of colon cancer cells through decreases in Wnt1/beta-catenin signaling . Biochem Biophys Res Commun. 2017; ; 482 : :8.–14.
44.
Saba NF, Magliocca KR, Kim S, et al. Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck . Head Neck Pathol. 2014; ; 8 : :66.–72.
45.
Aguilar A, Becker L, Tedeschi T, et al. Alpha-tubulin K40 acetylation is required for contact inhibition of proliferation and cell-substrate adhesion . Mol Biol Cell. 2014; ; 25 : :1854.–1866.
46.
Wickstrom SA, Masoumi KC, Khochbin S, et al. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin . EMBO J. 2010; ; 29 : :131.–144.
47.
Aldana-Masangkay GI, Rodriguez-Gonzalez A, Lin T, et al. Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells . Leuk Lymphoma. 2011; ; 52 : :1544.–1555.
48.
Lee JH, Mahendran A, Yao Y, et al. Development of a histone deacetylase 6 inhibitor and its biological effects . Proc Natl Acad Sci U S A. 2013; ; 110 : :15704.–15709.
49.
Lafanechere L, Courtay-Cahen C, Kawakami T, et al. Suppression of tubulin tyrosine ligase during tumor growth . J Cell Sci. 1998; ; 111 : Pt 2 :171.–181.
50.
Kato C, Miyazaki K, Nakagawa A, et al. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis . Int J Cancer. 2004; ; 112 : :365.–375.
51.
Mialhe A, Lafanechere L, Treilleux I, et al. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis . Cancer Res. 2001; ; 61 : :5024.–5027.
52.
Whipple RA, Matrone MA, Cho EH, et al. Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement . Cancer Res. 2010; ; 70 : :8127.–8137.
53.
Watanabe K, Hasegawa Y, Yamashita H, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis . J Clin Invest. 2004; ; 114 : :898.–907.
54.
Kobayashi H, Kosaka T, Mikami S, et al. Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer . Oncotarget. 2018; ; 9 : :10203.–10210.
55.
Kapoor S.. Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas . Expert Opin Ther Targets. 2013; ; 17 : :105.–106.
56.
Sabo Y, Walsh D, Barry DS, et al. HIV-1 induces the formation of stable microtubules to enhance early infection . Cell Host Microbe. 2013; ; 14 : :535.–546.
57.
Zhou J, Scherer J, Yi J, Vallee RB. Role of kinesins in directed adenovirus transport and cytoplasmic exploration . PLoS Pathog. 2018; ; 14 : :e1007055..
58.
Nakashima H, Kaufmann JK, Wang PY, et al. Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma . J Clin Invest. 2015; ; 125 : :4269.–4280.
59.
Zhang D, Wu CT, Qi X, et al. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of alpha-tubulin proteostasis in experimental and human atrial fibrillation . Circulation. 2014; ; 129 : :346.–358.
60.
McLendon PM, Ferguson BS, Osinska H, et al. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy . Proc Natl Acad Sci U S A. 2014; ; 111 : :E5178.–E5186.
61.
Wang Z, Leng Y, Wang J, et al. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of alpha-tubulin acetylation and FGF-21 up-regulation . Sci Rep. 2016; ; 6 : :19626..
62.
Belmadani S, Pous C, Fischmeister R, Mery PF. Post-translational modifications of tubulin and microtubule stability in adult rat ventricular myocytes and immortalized HL-1 cardiomyocytes . Mol Cell Biochem. 2004; ; 258 : :35.–48.
63.
Robison P, Caporizzo MA, Ahmadzadeh H, et al. Detyrosinated microtubules buckle and bear load in contracting cardiomyocytes . Science. 2016;; 352 : aaf0659..
64.
Kerr JP, Robison P, Shi G, et al. Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle . Nat Commun. 2015; ; 6 : :8526..
65.
Ran J, Yang Y, Li D, et al. Deacetylation of alpha-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly . Sci Rep. 2015; ; 5 : :12917..
66.
Moutin MJ, Bosc C, Peris L, Andrieux A. La boucle est bouclée : des complexes enzymatiques qui détyrosinent les microtubules enfin découverts . Med Sci (Paris). 2018; ; 34 : :1022.–1025.